Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.45 |
| ▸ | NAMPT | P43490 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NHERF1 | O14745 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2992280 | 0.86 | ACLY (0.48) | ALDH1A1SMN1; SMN2POLBKMT2AMEN1 | |
| SCHEMBL2983173 | 0.85 | SMN1; SMN2 (0.54) | ALDH1A1KDM4ESMN1; SMN2MAPK1POLB | |
| SCHEMBL2990833 | 0.82 | ALDH1A1 (0.52) | ALDH1A1KDM4ESMN1; SMN2MAPK1POLB | |
| SCHEMBL2984396 | 0.81 | MAPT (0.53) | ALDH1A1KDM4ESMN1; SMN2POLBKMT2A | |
| SCHEMBL4666015 | 0.76 | ALDH1A1 (0.52) | ALDH1A1KDM4ESMN1; SMN2MAPK1POLB | |
| SCHEMBL2995707 | 0.76 | ALDH1A1 (0.46) | ALDH1A1KDM4ESMN1; SMN2MAPK1POLB | |
| SCHEMBL2983460 | 0.76 | ALDH1A1 (0.53) | ALDH1A1KDM4ESMN1; SMN2MAPK1POLB | |
| SCHEMBL2985933 | 0.75 | ACLY (0.47) | KMT2AMEN1LMNAMAPTHTT | |
| SCHEMBL2985941 | 0.74 | GHSR (0.53) | ALDH1A1SMN1; SMN2MAPK1POLBKMT2A | |
| SCHEMBL2989977 | 0.74 | GHSR (0.46) | ALDH1A1SMN1; SMN2POLBKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100179168-A1 | ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS | BLANEY EMMA LOUISE | 2010-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179168-A1 | ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS | GHSR, GHRHR, GIPR | ALDH1A1 2521/4885KDM4E 3009/4885SMN1; SMN2 2538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.